IRIS
MARCHESE, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 41.416
AS - Asia 4.805
NA - Nord America 4.542
SA - Sud America 415
Continente sconosciuto - Info sul continente non disponibili 253
AF - Africa 103
OC - Oceania 4
Totale 51.538
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 40.564
US - Stati Uniti d'America 4.260
SG - Singapore 2.043
CN - Cina 1.135
VN - Vietnam 727
BD - Bangladesh 410
FR - Francia 410
BR - Brasile 244
HK - Hong Kong 160
FI - Finlandia 108
CA - Canada 106
DE - Germania 78
AR - Argentina 66
GB - Regno Unito 54
MX - Messico 51
JP - Giappone 48
IN - India 37
IQ - Iraq 36
CH - Svizzera 34
ID - Indonesia 34
JM - Giamaica 34
NL - Olanda 31
CO - Colombia 28
EC - Ecuador 26
CR - Costa Rica 23
ZA - Sudafrica 21
ES - Italia 20
TH - Thailandia 19
RU - Federazione Russa 18
PH - Filippine 17
VE - Venezuela 17
MY - Malesia 16
SA - Arabia Saudita 16
IE - Irlanda 14
UZ - Uzbekistan 13
MA - Marocco 12
TR - Turchia 12
TT - Trinidad e Tobago 12
HN - Honduras 11
DZ - Algeria 10
EG - Egitto 10
KR - Corea 10
PK - Pakistan 10
PY - Paraguay 10
SC - Seychelles 10
UA - Ucraina 10
PL - Polonia 9
CL - Cile 8
KE - Kenya 8
PE - Perù 8
SE - Svezia 8
GT - Guatemala 7
JO - Giordania 7
NI - Nicaragua 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
ET - Etiopia 6
KZ - Kazakistan 6
NP - Nepal 6
SK - Slovacchia (Repubblica Slovacca) 6
SV - El Salvador 6
UY - Uruguay 6
BG - Bulgaria 5
HU - Ungheria 5
LY - Libia 5
OM - Oman 5
PR - Porto Rico 5
RO - Romania 5
AO - Angola 4
BB - Barbados 4
BH - Bahrain 4
HR - Croazia 4
PT - Portogallo 4
TW - Taiwan 4
AG - Antigua e Barbuda 3
AU - Australia 3
BE - Belgio 3
DO - Repubblica Dominicana 3
EE - Estonia 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
RE - Reunion 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AT - Austria 2
BO - Bolivia 2
BS - Bahamas 2
CG - Congo 2
IM - Isola di Man 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
PS - Palestinian Territory 2
AL - Albania 1
BF - Burkina Faso 1
BM - Bermuda 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
Totale 51.260
Salva come PNG Salva come JPEG
Città #
Genova 23.538
Genoa 9.431
Rapallo 4.270
Vado Ligure 2.599
San Jose 1.212
Singapore 993
Ashburn 390
Lauterbourg 372
New York 236
Ho Chi Minh City 230
Hanoi 162
Beijing 152
Hong Kong 148
Santa Clara 139
Helsinki 105
Bordighera 96
Los Angeles 77
Dallas 72
Milan 70
Frankfurt am Main 58
Rome 58
Chicago 55
Phoenix 55
Council Bluffs 43
Tokyo 40
Buffalo 37
Naples 35
Zurich 34
Mexico City 30
Haiphong 29
Da Nang 27
Orem 25
San Francisco 25
Amsterdam 24
São Paulo 24
Atlanta 23
Houston 23
Tianjin 22
Florence 20
Kingston 19
San José 19
Bologna 18
Las Vegas 18
Montreal 17
Philadelphia 17
San Antonio 17
The Bronx 17
Biên Hòa 16
Brasília 16
Brooklyn 16
Charlotte 16
Denver 16
Palermo 16
Baghdad 14
Hải Dương 14
Turin 14
Johannesburg 13
London 13
Miami 13
Toronto 13
Boardman 12
Dublin 12
Guangzhou 12
Washington 12
Bari 11
Queens 11
Baltimore 10
Kansas City 10
Seattle 10
Des Moines 9
Dhaka 9
Guayaquil 9
Modena 9
Shenzhen 9
Bangkok 8
Cardiff 8
Louisville 8
Nuremberg 8
Princeton 8
Quảng Ngãi 8
San Diego 8
Shanghai 8
Tampa 8
Amman 7
City of London 7
Lima 7
Medellín 7
Memphis 7
Mumbai 7
Nairobi 7
Orlando 7
Pensacola 7
Tashkent 7
Warsaw 7
Boston 6
Can Tho 6
Catania 6
Charleston 6
Columbus 6
Curitiba 6
Totale 45.641
Salva come PNG Salva come JPEG
Nome #
Confronto tra gli effeti dei mucolitici N-acetilcisteina, ambroxol, bromexina e sobrerolo sulla sintesi e sulla degradazione di biofilm di Staphylococcus aureus. 1.797
Presynaptic release-regulating α2 receptors and Urolithins: A bridge between systemic EA administration and central health properties 276
Potentially human pathogenic vibrios in marine and fresh bathing waters related to environmental conditions and disease outcome 275
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 251
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 238
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 237
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 235
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 228
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 219
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 211
Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction 209
. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance 205
Epidemiological study of pathogens isolated from blood in Liguria during 2011. 203
A Fatal Case of Nosocomial Legionnaires' Disease: Implications From an Extensive Environmental Investigation and Isolation of the Bacterium From Blood Culture. 200
DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia. 197
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 195
. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 195
Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint 195
Antibiotic susceptibility patterns and serotypes of antibiotic resistant and or invasive Streptococcus pneumoniae strains circulating in Italy 195
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 193
Efficacy of N-acetyl-cysteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even when sustained by bacterial biofilms 192
Active surveillance of Streptococcus pneumoniae bacteremia in Italian children 190
Antibacterial activity of polyphenols. 190
Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients. 189
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis 188
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 187
Activity of Bay 12-8039 against well-characterised antibiotic resistant S.pyogenes. 184
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 184
Bloodstream infections in critically ill patients with COVID-19 184
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. 183
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 182
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. 176
Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. 176
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 175
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 174
Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity 173
Adesione batterica e fungina a materiali protesici del cavo orale. 172
In vitro antimicrobial activity of tigecycline against Gram-negative and Gram-positive pathogens collected in Northen Italy (T.E.S.T. program 2010). 170
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 169
Breast implant infection due to Paenibacillus residui in a cancer patient 169
Clinical and Microbiological Characterization of Late Breast Implant Infections after Reconstructive Breast Cancer Surgery 169
Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting 168
Influence of in vitro simulated gastroduodenal digestion on the antibacterial activity, metabolic profiling and polyphenols content of green tea (Camellia sinensis). 168
Does the adoption of EUCAST susceptibility breackpoints affects the selection of antimicrobials to treat acute community-acquired respiratory tract infections? 167
Epidemiology of multi-resistance Gram negative pathogen circulating in Liguria and molecular characterization of different carbapenemases. 167
Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections. 167
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. 164
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery 164
Characterization of Fluoroquinolone-Resistant Escherichia coli Causing Septicemic Colibacillosis in Calves in Italy: Emergence of a Multiresistant O78 Clonal Group. 163
Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC). 163
Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). 163
Activity of Teicoplanin, Vancomycin and 8 Other Drugs Against Gram-Positive Pathogens Isolated in Italy 162
Antibiotic persistence: the role of spontaneous DNA repair response 161
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. 161
Antistaphylococcal activity and metabolite profiling of manuka honey (Leptospermum scoparium L.) after in vitro simulated digestion 160
A new in vitro model system to study antimycotic drugs. 156
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 155
The role of macrolides in Streptococcus pyogenes pharyngitis. 155
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 154
Post antibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA 154
Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy. 153
Antibiotic resistance among S.pneumoniae isolated in Italy. 153
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 153
Antibiotic susceptibility patterns and serotypes of nasopharyngeal Streptococcus pneumoniae circulating in healthy italian children. 152
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 152
Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults 150
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 150
Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy 149
Interazione sinergica di teicoplanina e vancomicina con ceftazidime e azitromicina nei confronti di Pseudomonas aeruginosa. 149
AmpC-type plasmid mediated beta-lactamase in Klebsiella oxytoca e K.pneumoniae. 148
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance 148
Predictors of Mortality in Bloodstream Infections Caused by KPC-Producing Klebsiella pneumoniae: Importance of Combination Therapy. 148
Epidemiological study of pathogens isolated from blood in Liguria (January-April 2010). 148
Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders 146
F'lac integrative suppression in gyrB(Ts) mutan 146
Activity of moxifloxacin (Bay 12-8039) against erythromycin-resistant Streptococcus pyogenes. 145
Resistance patterns of lower respiratory tract pathogens in Europe. 144
Detection of macrolide resistance genes in Streptococcus pneumoniae using a rapid method 144
Attività antibatterica di N-acetilcisteina sui principali patogeni responsabili di infezioni delle alte vie respiratorie e sui germi del cavo orale. 144
European survey of glycopeptide susceptibility: Staphylococcus spp. 144
Antibiotic susceptibility tests directly on urine samples using Uro-Quick, a rapid automated system 144
Antibiotic persistence: the role of spontaneous DNA repair. 143
Activity of levofloxacin on contemporary respiratory pathogens 143
Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy. 143
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 143
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis 142
Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review 142
Isolation of Candida auris from invasive and noninvasive samples of a patient suffering from vascular disease, Italy, July 2019 142
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. 141
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. 141
Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 140
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. 140
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. 140
Antimicrobial activity of algae extracts against bacteria isolated from ear swabs. 140
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 139
The oxazolidinones as a new family of antimicrobial agent. 139
Genotypes and population genetics of cryptococcus neoformans and cryptococcus gattii species complexes in Europe and the mediterranean area 139
Pleiotropic effect of sodium arsenite on Escherichia coli 138
In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa. 138
A pain in the back: anaerobic vertebral spondylitis of hematogenous origin 138
Totale 18.583
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.989
article - articoli 104.980
book - libri 0
conference - conferenze 56.684
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 325
Totale 323.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.321 0 0 209 603 278 264 426 1.144 158 449 139 651
2022/20235.162 535 275 125 478 789 976 47 452 902 81 431 71
2023/20242.365 133 355 74 217 213 461 123 157 120 69 114 329
2024/20256.083 190 578 246 425 781 568 564 785 323 366 512 745
2025/202611.463 1.178 469 524 824 1.388 1.285 1.842 597 842 1.146 669 699
2026/20272.752 1.211 446 1.095 0 0 0 0 0 0 0 0 0
Totale 51.538